Table 4.
Metabolites and their pathways which are different between autism spectrum disorder with neurodevelopmental regression and control participants.
Significant Metabolites | Significant Pathways | |||
---|---|---|---|---|
Metabolite | Fold ∆ | Pathway | Matched Metabolites | Impact |
Cytidine *** | 9.66 | Aminoacyl-tRNA biosynthesis *** |
L-Asparagine *, L-Histidine *,
Glycine **, L-Serine ** |
0.17 |
Taurine *** | 7.54 | |||
Adenosine triphosphate *** | 6.86 | Histidine metabolism ** | L-Histidine*, 1-Methylhistamine * | 0.31 |
Glycine ** | 6.49 | Glyoxylate and dicarboxylate metabolism * | L-Serine **, Glycine ** | 0.15 |
Dodecanoic acid ** | 0.20 | Glycine, serine and threonine metabolism * | L-Serine **, Glycine ** | 0.46 |
D,L-Acetyl-carnitine ** | 4.84 | |||
Dihydroxyacetone ** | 4.76 | |||
Acetamide ** | 4.69 | |||
L-Histidine ** | 4.60 | |||
Hydroxykynurenine ** | 4.54 | |||
L-Serine ** | 4.49 | |||
1-Methylhistamine * | 4.16 | |||
L-Asparagine * | 3.94 | |||
trans-Aconitic acid * | 0.28 | |||
2,3,4,5-Tetrahydroxypentanoic acid * | 3.49 | |||
Capric acid * | 0.30 | |||
Heptadecanoic acid * | 3.33 | |||
2-Aminoisobutyric acid * | 3.31 | |||
Isobutyric acid * | 3.27 |
* p ≤ 0.05, ** p ≤ 0.01; *** p ≤ 0.001.